“…Cumulative incidence of SMN at 25 years was 6.1% for GGCTs and 4.1% for NGGCTs, which is comparable to previously reported cumulative incidence of 6.4% at 30 years for pediatric CNS malignancies. 14 In our cohort, deaths due SMN or recurrent disease accounted for 29 of 54 deaths (54%).…”
Section: Discussionmentioning
confidence: 80%
“…When analyzing the late causes of death in 5-year survivors of pediatric CNS malignancies, Perkins et al found that 50% of the deaths were attributable to recurrent disease. 14 The CCSS demonstrated that the annual risk of death from recurrence or progression of primary was 0.44% per year, but this varied across diagnostic groups with the highest rates being in Ewing's sarcoma (0.95% per year) and CNS tumors (1.14% per year for medulloblastoma and 0.95% per year for other CNS tumors). 12 Nordic data from populationbased registries assessed cause of death in 37 515 five-year survivors of childhood and adolescent cancer and categorized them as follows: death due to the first cancer, death due to a second or subsequent primary cancer, or death due to a noncancer-related cause.…”
Although CNS germinomas have favorable cure rates, late recurrences, subsequent malignancies, and stroke significantly affect long-term survival. Close attention to long-term follow-up with assessment of stroke risk factors is recommended.
“…Cumulative incidence of SMN at 25 years was 6.1% for GGCTs and 4.1% for NGGCTs, which is comparable to previously reported cumulative incidence of 6.4% at 30 years for pediatric CNS malignancies. 14 In our cohort, deaths due SMN or recurrent disease accounted for 29 of 54 deaths (54%).…”
Section: Discussionmentioning
confidence: 80%
“…When analyzing the late causes of death in 5-year survivors of pediatric CNS malignancies, Perkins et al found that 50% of the deaths were attributable to recurrent disease. 14 The CCSS demonstrated that the annual risk of death from recurrence or progression of primary was 0.44% per year, but this varied across diagnostic groups with the highest rates being in Ewing's sarcoma (0.95% per year) and CNS tumors (1.14% per year for medulloblastoma and 0.95% per year for other CNS tumors). 12 Nordic data from populationbased registries assessed cause of death in 37 515 five-year survivors of childhood and adolescent cancer and categorized them as follows: death due to the first cancer, death due to a second or subsequent primary cancer, or death due to a noncancer-related cause.…”
Although CNS germinomas have favorable cure rates, late recurrences, subsequent malignancies, and stroke significantly affect long-term survival. Close attention to long-term follow-up with assessment of stroke risk factors is recommended.
“…Brain tumors (BTs) are the most common solid tumors in childhood [1], and currently, close to 80% of childhood BT patients survive at least 5 years [2]. The survivors have an elevated risk for a number of late-effects [3][4][5][6][7][8]. Quality of life (QOL) has been extensively studied in survivors.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.